BACKGROUND: The purpose of this study is to determine the outcome and performance of bovine pericardial valves in the pulmonary position. METHODS: This is a retrospective review of all patients with congenital heart disease who had pulmonary valve replacement using a bovine pericardial valve from 2002 to 2009 at a single institution. RESULTS: There were 73 consecutive patients, with a median age of 17.3 years (range, 2.1 to 64.4). Their diagnosis was tetralogy of Fallot (n = 47), pulmonary stenosis (n = 11), or other (n = 15). Sixty-nine patients had 91 previous surgical procedures. The mean time from last surgery was 19.9 ± 11.6 years. Forty-three patients had concomitant surgical procedures. There were no perioperative deaths. Clinical follow-up was available in 68 patients (93%). There were no late deaths, and all patients were in New York Heart Association functional class I during a median follow-up period of 2.6 years (range, 0.2 to 8.0). One patient had endocarditis necessitating valve removal 2 years after surgery. Freedom from pulmonary valve reoperation was 100%, 97.7%, and 97.7% at 1, 3, and 5 years, respectively (95% confidence interval: 93.2% to 100%). Mean pulmonary valve gradient at follow-up was 19 ± 14 mm Hg. Degree of pulmonary insufficiency was less than moderate in 62 patients, moderate in 4, and more than moderate in 2. Freedom from moderate-severe or severe pulmonary insufficiency was 97.7%, 89.1%, and 89.1% at 1, 3, and 5 years, respectively (5-year 95% confidence interval: 77.0% to 100%). CONCLUSIONS: Pulmonary valve replacement using a bovine pericardial valve can be accomplished with low perioperative morbidity and favorable midterm outcomes. Further follow-up is necessary to evaluate the long-term performance of bovine pericardial valves in the pulmonary position.
BACKGROUND: The purpose of this study is to determine the outcome and performance of bovine pericardial valves in the pulmonary position. METHODS: This is a retrospective review of all patients with congenital heart disease who had pulmonary valve replacement using a bovine pericardial valve from 2002 to 2009 at a single institution. RESULTS: There were 73 consecutive patients, with a median age of 17.3 years (range, 2.1 to 64.4). Their diagnosis was tetralogy of Fallot (n = 47), pulmonary stenosis (n = 11), or other (n = 15). Sixty-nine patients had 91 previous surgical procedures. The mean time from last surgery was 19.9 ± 11.6 years. Forty-three patients had concomitant surgical procedures. There were no perioperative deaths. Clinical follow-up was available in 68 patients (93%). There were no late deaths, and all patients were in New York Heart Association functional class I during a median follow-up period of 2.6 years (range, 0.2 to 8.0). One patient had endocarditis necessitating valve removal 2 years after surgery. Freedom from pulmonary valve reoperation was 100%, 97.7%, and 97.7% at 1, 3, and 5 years, respectively (95% confidence interval: 93.2% to 100%). Mean pulmonary valve gradient at follow-up was 19 ± 14 mm Hg. Degree of pulmonary insufficiency was less than moderate in 62 patients, moderate in 4, and more than moderate in 2. Freedom from moderate-severe or severe pulmonary insufficiency was 97.7%, 89.1%, and 89.1% at 1, 3, and 5 years, respectively (5-year 95% confidence interval: 77.0% to 100%). CONCLUSIONS:Pulmonary valve replacement using a bovine pericardial valve can be accomplished with low perioperative morbidity and favorable midterm outcomes. Further follow-up is necessary to evaluate the long-term performance of bovine pericardial valves in the pulmonary position.
Authors: Alexander van Straten; Hubert W Vliegen; Mark G Hazekamp; Jeroen J Bax; Paul H Schoof; Jaap Ottenkamp; Ernst E van der Wall; Albert de Roos Journal: Radiology Date: 2004-12 Impact factor: 11.105
Authors: W R Eric Jamieson; M A Marchand; C L Pelletier; R Norton; M Pellerin; T W Dubiel; M R Aupart; W J Daenen; M P Holden; T E David; E A Ryba; W N Anderson Journal: J Thorac Cardiovasc Surg Date: 1999-08 Impact factor: 5.209
Authors: J Therrien; S C Siu; L Harris; A Dore; K Niwa; J Janousek; W G Williams; G Webb; M A Gatzoulis Journal: Circulation Date: 2001-05-22 Impact factor: 29.690
Authors: M A Gatzoulis; S Balaji; S A Webber; S C Siu; J S Hokanson; C Poile; M Rosenthal; M Nakazawa; J H Moller; P C Gillette; G D Webb; A N Redington Journal: Lancet Date: 2000-09-16 Impact factor: 79.321
Authors: Bradley S Allen; Chawki El-Zein; Betina Cuneo; Joseph P Cava; Mary Jane Barth; Michel N Ilbawi Journal: Ann Thorac Surg Date: 2002-09 Impact factor: 4.330
Authors: Kirk R Kanter; Jason M Budde; W James Parks; Vincent K H Tam; Shiva Sharma; Willis H Williams; Derek A Fyfe Journal: Ann Thorac Surg Date: 2002-06 Impact factor: 4.330
Authors: Andrew C Fiore; Mark Rodefeld; Mark Turrentine; Palaniswamy Vijay; Tyler Reynolds; John Standeven; Kirstin Hill; Jamie Bost; Dustin Carpenter; Courtney Tobin; John W Brown Journal: Ann Thorac Surg Date: 2008-05 Impact factor: 4.330
Authors: Christopher E Mascio; Sara K Pasquali; Jeffrey P Jacobs; Marshall L Jacobs; Erle H Austin Journal: J Thorac Cardiovasc Surg Date: 2011-09-10 Impact factor: 5.209
Authors: Jamie L R Romeo; Johanna J M Takkenberg; Judith A A E Cuypers; Natasha M S de Groot; Pieter van de Woestijne; Nico Bruining; Ad J J C Bogers; M Mostafa Mokhles Journal: Eur J Cardiothorac Surg Date: 2020-09-01 Impact factor: 4.191